Home2018-07-27T04:33:28+00:00

Novel cancer therapies targeting key cancer pathways

READ MORE
Prescient Therapeutics PTX

We are a clinical stage oncology company developing novel drugs
that show great promise as potential new therapies to treat a range of cancers.

prescient therapeutics

OUR COMPANY

Prescient Therapeutics’ novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.

Digital Brochure

Two Page Fact Sheet

prescient therapeutics

OUR SCIENCE

Our technologies emanate from renowned institutions Yale University and the Moffitt Cancer Center and are backed by a myriad of peer review publications.

prescient therapeutics

LATEST NEWS

24/09/2018Canadian Patent Granted for PTX-200PDF
05/09/2018Rodman & Renshaw Global Investment Conference PresentationPDF
04/09/2019PTX to present at Rodman & Renshaw Investment conferencePDF
03/09/2018Improved manufacturing route for PTX-100PDF
31/08/2018Appendix 4G and Corporate Governance StatementPDF
31/08/2018Appendix 4E and 2018 Annual ReportPDF